Research correspondence

DOI: 10.4244/EIJ-D-22-01058

Clinical performance of a novel hybrid IVUS-OCT system: a multicentre, randomised, non-inferiority trial (PANOVISION)

Haibo Jia1,2, MD, PhD; Chen Zhao1,2, MD; Huai Yu1,2, MD; Zhao Wang3, PhD; Huimin Liu1,2, MD, PhD; Maoen Xu1,2, MD, PhD; Sining Hu1,2, MD, PhD; Lulu Li1,2, PhD; Luping He1,2, MD; Ziqian Weng1,2, MD; Yuhan Qin1,2, MD; Yishuo Xu1,2, MD; Ming Zeng1,2, MD; Xi Su4, MD, PhD; Bin Liu5, MD, PhD; Jingbo Hou1,2, MD, PhD; Bo Yu1,2, MD, PhD

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have been established as important diagnostic and guidance tools for percutaneous coronary intervention (PCI) procedures1. Sequential use of the two modalities might overcome the inherent limitations of each technology; however, the potential risks of complications and cost are hard to ignore. Hybrid IVUS-OCT systems can overcome the limitations associated with each technology and integrate the advantages of both modalities. In 2018, a hybrid IVUS-OCT system for clinical application was reported for the first time2. Recently, a novel hybrid imaging system was approved for clinical use (PANOVISON; Panovision Co., Ltd), allowing synchronous acquisition of the two imaging modalities and an immediate, coregistered image review. We conducted this first-in-human study to test each modality of the hybrid imaging system, representing this novel device’s first large-scale human application.

The study was a prospective, multicentre, randomised, open-label, self-controlled, non-inferiority trial. The protocol was approved by the institutional review boards and ethics committees in all participating centres. All patients provided written informed consent. Specific inclusion and exclusion criteria are described at ClinicalTrials.gov: NCT05596279. We used a web-based randomisation service...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 19 Number 4
Jul 17, 2023
Volume 19 Number 4
View full issue


Key metrics

On the same subject

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free

10.4244/EIJV12I13A257 Jan 20, 2017
Small details make a big difference
Kang D and Park S
free
Trending articles
281.53

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved